PharmaCyte Biotech, Inc.
PMCB
$0.55
$0.000.73%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 138.65% | 22.57% | -25.11% | -58.82% | -69.03% |
| Total Receivables | -93.48% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -56.70% | -23.48% | 2.01% | -0.83% | -13.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 67.24% | 22.01% | 7.92% | -41.88% | -55.64% |
|
|
|||||
| Total Current Assets | 67.24% | 22.01% | 7.92% | -41.88% | -55.64% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.42% | 66.86% | 44.79% | -27.52% | 10.80% |
| Total Assets | -15.25% | 27.48% | 1.59% | -35.73% | -7.91% |
|
|
|||||
| Total Accounts Payable | -32.09% | 147.49% | 192.97% | -16.03% | 2.52% |
| Total Accrued Expenses | 95.87% | -51.27% | -51.12% | -49.47% | -29.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -95.49% | -- | -94.34% | -95.99% | -68.33% |
| Total Other Current Liabilities | -95.49% | -- | -94.34% | -95.99% | -68.33% |
| Total Current Liabilities | -71.64% | 40.51% | -66.97% | -85.80% | -60.73% |
|
|
|||||
| Total Current Liabilities | -71.64% | 40.51% | -66.97% | -85.80% | -60.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2,915.43% | 520.51% | 159.71% | -95.27% | -97.20% |
| Total Liabilities | 259.21% | 360.30% | 66.76% | -91.14% | -83.93% |
|
|
|||||
| Common Stock & APIC | 0.68% | 0.95% | -0.41% | -0.64% | -2.07% |
| Retained Earnings | -22.86% | -3.39% | -7.55% | -1.22% | 26.51% |
| Treasury Stock & Other | 0.04% | -0.35% | 0.04% | -4.25% | -6.11% |
| Total Common Equity | -35.03% | -4.27% | -17.95% | -8.63% | 87.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.03% | -4.27% | -17.95% | -8.63% | 87.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.59% | -2.11% | -15.87% | -17.82% | 31.32% |
|
|
|||||